Hikma Pharmaceuticals PLC (FRA:H5P)
Germany · Delayed Price · Currency is EUR 18.00
+0.20 (1.12%)
At close: Jan 28, 2026
Hikma Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 371 | 359 | 190 | 188 | 421 | 431 |
Depreciation & Amortization | 194 | 189 | 190 | 185 | 169 | 125 |
Other Amortization | 8 | 8 | 8 | 8 | 11 | 10 |
Loss (Gain) From Sale of Assets | 1 | 1 | - | -6 | 1 | 2 |
Asset Writedown & Restructuring Costs | -29 | -29 | 61 | 179 | -35 | -44 |
Loss (Gain) From Sale of Investments | -2 | -1 | -2 | 2 | - | -1 |
Loss (Gain) on Equity Investments | - | -1 | - | - | 1 | - |
Stock-Based Compensation | 28 | 27 | 25 | 22 | 29 | 27 |
Other Operating Activities | 13 | 146 | 56 | 83 | 69 | 122 |
Change in Accounts Receivable | -121 | -144 | -24 | 4 | -166 | -47 |
Change in Inventory | -108 | -112 | -115 | -102 | 38 | -180 |
Change in Accounts Payable | 58 | 78 | 88 | 16 | 14 | 6 |
Change in Other Net Operating Assets | 114 | 43 | 131 | -49 | 86 | 13 |
Operating Cash Flow | 527 | 564 | 608 | 530 | 638 | 464 |
Operating Cash Flow Growth | -9.76% | -7.24% | 14.72% | -16.93% | 37.50% | -1.70% |
Capital Expenditures | -164 | -165 | -169 | -138 | -145 | -172 |
Sale of Property, Plant & Equipment | 1 | - | 18 | 1 | - | - |
Cash Acquisitions | -150 | -150 | -98 | -373 | - | - |
Divestitures | - | - | - | -1 | - | - |
Sale (Purchase) of Intangibles | -135 | -70 | -35 | -78 | -84 | -52 |
Investment in Securities | -2 | -2 | -26 | -15 | 3 | -3 |
Other Investing Activities | -40 | 6 | -23 | -3 | -12 | -56 |
Investing Cash Flow | -490 | -381 | -333 | -607 | -238 | -283 |
Short-Term Debt Issued | - | 387 | 437 | 380 | 383 | 430 |
Long-Term Debt Issued | - | 684 | 778 | 1,401 | 10 | 1,543 |
Total Debt Issued | 1,191 | 1,071 | 1,215 | 1,781 | 393 | 1,973 |
Short-Term Debt Repaid | - | -411 | -467 | -363 | -431 | -367 |
Long-Term Debt Repaid | - | -557 | -851 | -971 | -76 | -1,386 |
Total Debt Repaid | -926 | -968 | -1,318 | -1,334 | -507 | -1,753 |
Net Debt Issued (Repaid) | 265 | 103 | -103 | 447 | -114 | 220 |
Repurchase of Common Stock | - | - | - | -300 | - | -375 |
Common Dividends Paid | -177 | -175 | -137 | -125 | -120 | -109 |
Other Financing Activities | -126 | -116 | -97 | -80 | -53 | -34 |
Financing Cash Flow | -38 | -188 | -337 | -58 | -287 | -298 |
Foreign Exchange Rate Adjustments | 1 | -12 | -3 | -21 | -10 | -2 |
Net Cash Flow | - | -17 | -65 | -156 | 103 | -119 |
Free Cash Flow | 363 | 399 | 439 | 392 | 493 | 292 |
Free Cash Flow Growth | -15.58% | -9.11% | 11.99% | -20.49% | 68.84% | -17.28% |
Free Cash Flow Margin | 11.29% | 12.76% | 15.27% | 15.57% | 19.31% | 12.47% |
Free Cash Flow Per Share | 1.63 | 1.78 | 1.97 | 1.74 | 2.12 | 1.23 |
Cash Interest Paid | 83 | 84 | 82 | 68 | 50 | 39 |
Cash Income Tax Paid | 149 | 125 | 129 | 55 | 129 | 61 |
Levered Free Cash Flow | 128.13 | 290.13 | 449 | 244.38 | 269.75 | 24.88 |
Unlevered Free Cash Flow | 172.5 | 337 | 494.63 | 281.25 | 296.63 | 50.5 |
Change in Working Capital | -57 | -135 | 80 | -131 | -28 | -208 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.